Anti-Staphylococcal and cytotoxic activities of the short anti-microbial peptide PVP
Over the past years, short anti-microbial peptides have drawn growing attention in the
research and trade literature because they are usually capable of killing a broad spectrum of …
research and trade literature because they are usually capable of killing a broad spectrum of …
Mechanism of action and in vitro activity of short hybrid antimicrobial peptide PV3 against Pseudomonas aeruginosa
H Memariani, D Shahbazzadeh, JM Sabatier… - Biochemical and …, 2016 - Elsevier
Antimicrobial peptides are attractive candidates for developing novel therapeutic agents,
since they are lethal to a broad spectrum of pathogens and have a unique low tendency for …
since they are lethal to a broad spectrum of pathogens and have a unique low tendency for …
Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes
L Li, YH Shi, MJ Cheserek, GF Su, GW Le - Applied microbiology and …, 2013 - Springer
A number of research have proven that antimicrobial peptides are of greatest potential as a
new class of antibiotics. Antimicrobial peptides and cell-penetrating peptides share some …
new class of antibiotics. Antimicrobial peptides and cell-penetrating peptides share some …
Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure–activity relationship study
QY Lau, FM Ng, JWD Cheong, YYA Yap… - European journal of …, 2015 - Elsevier
The overuse and misuse of antibiotics has resulted in the emergence of drug-resistant
pathogenic bacteria, including meticillin-resistant Staphylococcus aureus (MRSA), the …
pathogenic bacteria, including meticillin-resistant Staphylococcus aureus (MRSA), the …
Short hybrid peptides incorporating β-and γ-amino acids as antimicrobial agents
The peptides containing β-and γ-amino acids, LA-Lys (Z)-PEA, P1; LA-Lys (Z)-β 3, 3-Ac 6 c-
PEA, P2; LA-Orn (Z)-β 3, 3-Ac 6 c-PEA, P3; LA-Lys (Z)-Gpn-PEA, P4; LA-Orn (Z)-Gpn-PEA …
PEA, P2; LA-Orn (Z)-β 3, 3-Ac 6 c-PEA, P3; LA-Lys (Z)-Gpn-PEA, P4; LA-Orn (Z)-Gpn-PEA …
[HTML][HTML] A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35
A Barreto-Santamaría, H Curtidor… - Frontiers in …, 2016 - frontiersin.org
The increased resistance of microorganisms to the different antimicrobials available to today
has highlighted the need to find new therapeutic agents, including natural and/or synthetic …
has highlighted the need to find new therapeutic agents, including natural and/or synthetic …
Dual antimicrobial and anticancer activity of a novel synthetic α-helical antimicrobial peptide
B Thankappan, J Sivakumar, S Asokan… - European Journal of …, 2021 - Elsevier
Antimicrobial peptides (AMPs) are increasingly sought-after and researched antimicrobial
agents due to its desired pharmacological properties and the continuous diminishing …
agents due to its desired pharmacological properties and the continuous diminishing …
Short antimicrobial peptides
Background: After the era of serendipitous discovery of penicillin and outburst in the
discovery and development of highly efficient antibiotics, a surge in resistance against the …
discovery and development of highly efficient antibiotics, a surge in resistance against the …
Identification and design of antimicrobial peptides for therapeutic applications
Indiscriminate use of antibiotics has led to a rapid increase of antibiotic resistance among
microbes which has increased the need to develop novel antimicrobial agents to fight …
microbes which has increased the need to develop novel antimicrobial agents to fight …
Mini review on antimicrobial peptides, sources, mechanism and recent applications
JK Boparai, PK Sharma - Protein and peptide letters, 2020 - ingentaconnect.com
Antimicrobial peptides in recent years have gained increased interest among scientists,
health professionals and the pharmaceutical companies owing to their therapeutic potential …
health professionals and the pharmaceutical companies owing to their therapeutic potential …